Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)
- 15 May 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (10), 2865-2869
- https://doi.org/10.1016/j.bmcl.2009.03.080
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide HydrolaseAnesthesia & Analgesia, 2009
- Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) InhibitorsJournal of Medicinal Chemistry, 2008
- Structure-guided inhibitor design for human FAAH by interspecies active site conversionProceedings of the National Academy of Sciences, 2008
- Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseBioorganic & Medicinal Chemistry Letters, 2008
- Optimization of the Central Heterocycle of α-Ketoheterocycle Inhibitors of Fatty Acid Amide HydrolaseJournal of Medicinal Chemistry, 2008
- Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous SystemChemical Reviews, 2008
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl RingChemMedChem, 2006
- Discovering potent and selective reversible inhibitors of enzymes in complex proteomesNature Biotechnology, 2003
- Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid SignalingScience, 2002